시장보고서

상품코드

1587784

응고 분석기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 검사별, 최종 용도별, 부문별 예측(2025-2030년)

Coagulation Analyzer Market Size, Share & Trends Analysis Report By Product (Analyzers, Consumables), By Technology (Mechanical, Electrochemical, Optical), By Test (APTT), By End Use, And Segment Forecasts, 2025 - 2030

발행일: 2024년 10월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

응고 분석기 시장 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면 세계 응고 분석기 시장 규모는 2025년부터 2030년까지 연평균 5.2%의 CAGR을 기록하여 2030년에는 64억 3,000만 달러에 달할 것으로 예상됩니다.

응고 분석 장비의 기술 발전은 응고 분석기 시장의 유리한 성장을 가져오는 가장 영향력 있는 촉진제가 될 것으로 예상됩니다. 자동화는 최근 주요 트렌드입니다.

가장 관련성이 높은 발전은 하나의 장치에서 다양한 측정 절차를 결합하는 것으로, 프로트롬빈 시간(PT), 활성화된 부분 트롬보플라스틴 시간(APTT), D-다이머, 피브리노겐 등을 검사할 수 있는 다양한 지혈 분석기가 시판되고 있습니다.

또한, 이러한 시스템은 더 많은 검체를 보관하고 더 빠른 결과를 제공하고 실험실 워크플로우의 효율성을 향상시킬 수 있습니다. 지혈 분석기의 발전은 다음과 같습니다:

트랙라인 시스템 및 워크셀과의 통합을 통해 단일 검출 시스템 및 간섭 물질의 분석 전 검사 등 분석의 신뢰성을 향상시킬 수 있습니다.
불충분한 시료 레벨, 혈전, 캡 관통 등을 감지하는 고장 패턴 센서로 안전성과 시료 무결성을 향상시킵니다.
자동 반사 테스트, 반복 테스트, 재희석.

응고 분석기 시장 보고서 하이라이트

소모품은 2024년 61.0%의 가장 큰 매출 점유율을 차지하며 시장을 주도했습니다. 혈액 및 심혈관질환의 유병률이 증가함에 따라 정기적인 모니터링 및 검사가 필요해지면서 시약 및 검사 키트와 같은 소모품에 대한 수요가 증가하고 있습니다.
광학 기술은 2024년 61.8%의 최대 매출 점유율을 차지하며 시장을 장악했습니다. 이는 형광 및 포토메트릭 검출과 같은 기술 혁신으로 인해 응고 매개 변수를 보다 정확하게 측정하고 진단 능력을 향상시킬 수 있기 때문입니다.
프로트롬빈 시간(PT) 검사는 2024년 25.4%의 최대 매출 점유율을 차지하며 시장을 주도했습니다. 출혈성 질환 및 심혈관질환의 유병률 증가로 인해 응고 매개 변수에 대한 정기적 인 모니터링이 필요하며 PT 검사는 중요한 요소가되었습니다.
병원이 2024년 36.6%의 가장 큰 매출 점유율을 차지하며 시장을 주도하고 있습니다. 만성 혈액 질환과 심혈관질환의 유병률 증가가 이러한 성장을 주도하고 있습니다.
북미 응고 분석기 시장은 2024년 42.7%의 매출 점유율을 차지하며 세계 시장을 장악했습니다.

지역별 시장 점유율 분석, 2024년 및 2030년
지역 시장 대시보드
시장 규모, 예측 동향 분석, 2018-2030년 :
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 덴마크
- 스웨덴
아시아태평양
- 일본
- 중국
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제9장 경쟁 상황

참여자 개요
기업의 시장 포지션 분석
기업 분류
전략 매핑
기업 개요/상장 기업
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- Abbott Laboratories
- Thermo Fischer Scientific.
- Instrumentation Laboratory.
- Sysmex Corporation.
- International Technidyne Corporation.
- Beckman Coulter Inc.
- Helena Laboratories.
- Meril Life Sciences Pvt. Ltd.

ksm 24.11.25

Coagulation Analyzer Market Growth & Trends:

The global coagulation analyzer market size is expected to reach USD 6.43 billion by 2030, registering a CAGR of 5.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising technological advancements in coagulation analyzers are expected to be the most impact rendering driver for lucrative growth of the market. Automation is the key development that has occurred in recent years.

The most relevant advancement includes combination of different assay procedures in single equipment and various commercially available hemostasis analyzers, which are capable of performing tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), D-Dimer, and Fibrinogen as well as these machines can perform chromogenic and immunologic assays.

Moreover, these systems may have the capacity of holding more samples, providing faster results, and increasing the efficiency of laboratory workflow. The advancements in hemostasis analyzers are as follows:

Integration of the system with track line systems and work cells, which may improve the reliability of analysis in terms of single detection system and preanalytical check for interfering substances
Failure pattern sensors, which detect insufficient sample levels and clots and cap piercing, which enhances safety and sample integrity
Automatic reflex testing, repeat testing, and redilution

Coagulation Analyzer Market Report Highlights:

Consumables led the market and accounted for the largest revenue share of 61.0% in 2024 attributed to the increasing prevalence of blood disorders and cardiovascular diseases, which necessitates regular monitoring and testing, leading to higher demand for consumables such as reagents and test kits.
Optical technology dominated the market and accounted for the largest revenue share of 61.8% in 2024 attributed to innovations such as fluorescence and photometric detection methods that enable more accurate measurement of coagulation parameters, improving diagnostic capabilities.
Prothrombin time (PT) testing led the market and accounted for the largest revenue share of 25.4% in 2024 driven by the increasing prevalence of bleeding disorders and cardiovascular diseases, necessitating regular monitoring of coagulation parameters, with PT testing being a critical component.
Hospitals led the market and accounted for the largest revenue share of 36.6% in 2024. The rising incidence of chronic blood disorders and cardiovascular diseases drives this growth.
The North America coagulation analyzer market dominated the global market and accounted for a revenue share of 42.7% in 2024 attributed to the region's advanced healthcare infrastructure and high prevalence of chronic diseases.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Test
- 1.2.4. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
1.6. Information Analysis
- 1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
- 1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Coagulation Analyzer Market Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis

Chapter 4. Coagulation Analyzer Market: Product Business Analysis

4.1. Product Market Share, 2024 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Analyzer
- 4.4.1. Analyzer Market, 2018 - 2030 (USD Million)
4.5. Consumables
- 4.5.1. Consumables Market, 2018 - 2030 (USD Million)

Chapter 5. Coagulation Analyzer Market: Technology Business Analysis

5.1. Technology Market Share, 2024 & 2030
5.2. Technology Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Million)
5.4. Mechanical
- 5.4.1. Mechanical Market, 2018 - 2030 (USD Million)
5.5. Electrochemical
- 5.5.1. Electrochemical Market, 2018 - 2030 (USD Million)
5.6. Optical
- 5.6.1. Optical Market, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Coagulation Analyzer Market: Test Business Analysis

6.1. Test Market Share, 2024 & 2030
6.2. Test Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Test, 2018 to 2030 (USD Million)
6.4. APTT
- 6.4.1. APTT Market, 2018 - 2030 (USD Million)
6.5. D-Dimer
- 6.5.1. D-Dimer Market, 2018 - 2030 (USD Million)
6.6. Fibrinogen
- 6.6.1. Fibrinogen Market, 2018 - 2030 (USD Million)
6.7. Prothrombin
- 6.7.1. Prothrombin Market, 2018 - 2030 (USD Million)
6.8. Others
- 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Coagulation Analyzer Market: End Use Business Analysis

7.1. End Use Market Share, 2024 & 2030
7.2. End Use Segment Dashboard
7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
7.4. Hospitals
- 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
7.5. Research Institutes
- 7.5.1. Research Institutes Market, 2018 - 2030 (USD Million)
7.6. Diagnostic Centers
- 7.6.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
7.7. Others
- 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Coagulation Analyzer Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2024 & 2030
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
8.4. North America
- 8.4.1. North America Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key Country Dynamics
  - 8.4.2.2. Regulatory Framework
  - 8.4.2.3. Competitive Insights
  - 8.4.2.4. U.S. Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key Country Dynamics
  - 8.4.3.2. Regulatory Framework
  - 8.4.3.3. Competitive Insights
  - 8.4.3.4. Canada Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key Country Dynamics
  - 8.4.4.2. Regulatory Framework
  - 8.4.4.3. Competitive Insights
  - 8.4.4.4. Mexico Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
- 8.5.1. Europe Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key Country Dynamics
  - 8.5.2.2. Regulatory Framework
  - 8.5.2.3. Competitive Insights
  - 8.5.2.4. UK Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key Country Dynamics
  - 8.5.3.2. Regulatory Framework
  - 8.5.3.3. Competitive Insights
  - 8.5.3.4. Germany Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key Country Dynamics
  - 8.5.4.2. Regulatory Framework
  - 8.5.4.3. Competitive Insights
  - 8.5.4.4. France Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key Country Dynamics
  - 8.5.5.2. Regulatory Framework
  - 8.5.5.3. Competitive Insights
  - 8.5.5.4. Italy Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key Country Dynamics
  - 8.5.6.2. Regulatory Framework
  - 8.5.6.3. Competitive Insights
  - 8.5.6.4. Spain Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key Country Dynamics
  - 8.5.7.2. Regulatory Framework
  - 8.5.7.3. Competitive Insights
  - 8.5.7.4. Norway Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.8. Denmark
  - 8.5.8.1. Key Country Dynamics
  - 8.5.8.2. Regulatory Framework
  - 8.5.8.3. Competitive Insights
  - 8.5.8.4. Denmark Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5.9. Sweden
  - 8.5.9.1. Key Country Dynamics
  - 8.5.9.2. Regulatory Framework
  - 8.5.9.3. Competitive Insights
  - 8.5.9.4. Sweden Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key Country Dynamics
  - 8.6.2.2. Regulatory Framework
  - 8.6.2.3. Competitive Insights
  - 8.6.2.4. Japan Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key Country Dynamics
  - 8.6.3.2. Regulatory Framework
  - 8.6.3.3. Competitive Insights
  - 8.6.3.4. China Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key Country Dynamics
  - 8.6.4.2. Regulatory Framework
  - 8.6.4.3. Competitive Insights
  - 8.6.4.4. India Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.5. South Korea
  - 8.6.5.1. Key Country Dynamics
  - 8.6.5.2. Regulatory Framework
  - 8.6.5.3. Competitive Insights
  - 8.6.5.4. South Korea Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.6. Australia
  - 8.6.6.1. Key Country Dynamics
  - 8.6.6.2. Regulatory Framework
  - 8.6.6.3. Competitive Insights
  - 8.6.6.4. Australia Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key Country Dynamics
  - 8.6.7.2. Regulatory Framework
  - 8.6.7.3. Competitive Insights
  - 8.6.7.4. Thailand Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
- 8.7.1. Latin America Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key Country Dynamics
  - 8.7.2.2. Regulatory Framework
  - 8.7.2.3. Competitive Insights
  - 8.7.2.4. Brazil Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key Country Dynamics
  - 8.7.3.2. Regulatory Framework
  - 8.7.3.3. Competitive Insights
  - 8.7.3.4. Argentina Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. MEA
- 8.8.1. MEA Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key Country Dynamics
  - 8.8.2.2. Regulatory Framework
  - 8.8.2.3. Competitive Insights
  - 8.8.2.4. South Africa Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key Country Dynamics
  - 8.8.3.2. Regulatory Framework
  - 8.8.3.3. Competitive Insights
  - 8.8.3.4. Saudi Arabia Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key Country Dynamics
  - 8.8.4.2. Regulatory Framework
  - 8.8.4.3. Competitive Insights
  - 8.8.4.4. UAE Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key Country Dynamics
  - 8.8.5.2. Regulatory Framework
  - 8.8.5.3. Competitive Insights
  - 8.8.5.4. Kuwait Coagulation Analyzer Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

9.1. Participant Overview
9.2. Company Market Position Analysis
9.3. Company Categorization
9.4. Strategy Mapping
9.5. Company Profiles/Listing
- 9.5.1. F. Hoffmann-La Roche Ltd
  - 9.5.1.1. Overview
  - 9.5.1.2. Financial performance
  - 9.5.1.3. Product benchmarking
  - 9.5.1.4. Strategic initiatives
- 9.5.2. Siemens Healthineers
  - 9.5.2.1. Overview
  - 9.5.2.2. Financial performance
  - 9.5.2.3. Product benchmarking
  - 9.5.2.4. Strategic initiatives
- 9.5.3. Abbott Laboratories
  - 9.5.3.1. Overview
  - 9.5.3.2. Financial performance
  - 9.5.3.3. Product benchmarking
  - 9.5.3.4. Strategic initiatives
- 9.5.4. Thermo Fischer Scientific.
  - 9.5.4.1. Overview
  - 9.5.4.2. Financial performance
  - 9.5.4.3. Product benchmarking
  - 9.5.4.4. Strategic initiatives
- 9.5.5. Instrumentation Laboratory.
  - 9.5.5.1. Overview
  - 9.5.5.2. Financial performance
  - 9.5.5.3. Product benchmarking
  - 9.5.5.4. Strategic initiatives
- 9.5.6. Sysmex Corporation.
  - 9.5.6.1. Overview
  - 9.5.6.2. Financial performance
  - 9.5.6.3. Product benchmarking
  - 9.5.6.4. Strategic initiatives
- 9.5.7. International Technidyne Corporation.
  - 9.5.7.1. Overview
  - 9.5.7.2. Financial performance
  - 9.5.7.3. Product benchmarking
  - 9.5.7.4. Strategic initiatives
- 9.5.8. Beckman Coulter Inc.
  - 9.5.8.1. Overview
  - 9.5.8.2. Financial performance
  - 9.5.8.3. Product benchmarking
  - 9.5.8.4. Strategic initiatives
- 9.5.9. Helena Laboratories.
  - 9.5.9.1. Overview
  - 9.5.9.2. Financial performance
  - 9.5.9.3. Product benchmarking
  - 9.5.9.4. Strategic initiatives
- 9.5.10. Meril Life Sciences Pvt. Ltd.
  - 9.5.10.1. Overview
  - 9.5.10.2. Financial performance
  - 9.5.10.3. Product benchmarking
  - 9.5.10.4. Strategic initiatives

응고 분석기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 기술별, 검사별, 최종 용도별, 부문별 예측(2025-2030년)

Coagulation Analyzer Market Size, Share & Trends Analysis Report By Product (Analyzers, Consumables), By Technology (Mechanical, Electrochemical, Optical), By Test (APTT), By End Use, And Segment Forecasts, 2025 - 2030

응고 분석기 시장 성장과 동향:

응고 분석기 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 응고 분석기 시장 변수, 동향, 범위

제4장 응고 분석기 시장 : 제품 비즈니스 분석

제5장 응고 분석기 시장 : 기술 비즈니스 분석

제6장 응고 분석기 시장 : 검사 비즈니스 분석

제7장 응고 분석기 시장 : 최종 용도 비즈니스 분석

제8장 응고 분석기 시장 : 지역 추정·동향 분석